First Time Loading...

Biocept Inc
NASDAQ:BIOC

Watchlist Manager
Biocept Inc Logo
Biocept Inc
NASDAQ:BIOC
Watchlist
Price: 0.0698 USD 125.16% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

BIOC Price Targets Summary
Biocept Inc

There are no price targets for BIOC.
BIOC Lowest Forecast
Wall Street Target
Not Available
BIOC Average Forecast
Wall Street Target
Not Available
BIOC Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biocept Inc Competitors:
Price Targets
KRRO
Korro Bio Inc
133% Upside
ADMA
ADMA Biologics Inc
29% Upside
HALO
Halozyme Therapeutics Inc
32% Upside
GNTA
Genenta Science SPA
611% Upside
KRRO
Korro Bio Inc
133% Upside
ADMA
ADMA Biologics Inc
29% Upside
HALO
Halozyme Therapeutics Inc
32% Upside
GNTA
Genenta Science SPA
611% Upside
CYTH
Cyclo Therapeutics Inc
173% Upside
RYTM
Rhythm Pharmaceuticals Inc
46% Upside
M
086900
Medy Tox Inc
78% Upside
DYAI
Dyadic International Inc
439% Upside

Revenue
Forecast

Revenue Estimate
Biocept Inc

For the last 8 years the compound annual growth rate for Biocept Inc's revenue is 94%. The projected CAGR for the next 2 years is -50%.

94%
Past Growth
-50%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Biocept Inc

Operating Income forecast
is not available for
Biocept Inc

Net Income
Forecast

Net Income Estimate
Biocept Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
BIOC intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIOC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIOC stock valuation using valuation multiples.
Wall Street Estimates
BIOC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIOC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOC's stock price target?
Not Available

BIOC doesn't have any price targets made by Wall Street professionals.

What is Biocept Inc's Revenue forecast?
Projected CAGR
-50%

For the last 8 years the compound annual growth rate for Biocept Inc's revenue is 94%. The projected CAGR for the next 2 years is -50%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.